USPTO serial 79221325
COSCI
Reviewed by CopyMark Law Group
Reg. 5505585Status 709
- Filing date
- Status date
- Registration date
- Jul 3, 2018
- Examiner
- HESIK, APRIL ANNE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with COSCI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Haidian District, CN
Haidian District, CN
Haidian District, CN
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Simone Chen
Simone Chen MUNCY, GEISSLER, OLDS & LOWE, P.C.4000 Legato Road, Suite 310Fairfax, VA 22033UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; dietetic foods adapted for medical purposes; air freshening preparations, namely, air purifying preparations, air deodorizing preparations; biological preparations for veterinary purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; pesticides; pharmaceutical preparations for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; chemical preparations for medical purposes for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; injections, namely, injectable pharmaceutical preparations for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; tablets, namely, pharmaceutical tablets for treatment of cardiovascular disease, psychosis, endocrinology, diabetes, cold, respiratory disease, heart disease, brain disease, and genetic disease; raw material medicine, namely, ethers, dextrins, and collodion for pharmaceutical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 19, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 4, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 4, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 17, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 17, 2025 | C71T | CANCELLED SECTION 71 | — |
| Jul 3, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 26, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 9, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 9, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 3, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 3, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 17, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 17, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 28, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 15, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 15, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 15, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 15, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 14, 2018 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 6, 2018 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 22, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 10, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 9, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 23, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 6, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 13, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 13, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 5, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 1, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 30, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 29, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 29, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 23, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |